antibiotics and semaglutide FBI warns about counterfeit weight loss drugs Australian regulator warns of 'rare

Specific Issues Semaglutide : Possibly has a slightly increased rate of gastrointestinal discomfort Tirzepatide : As it is newer, long-term data are still in the process of emerging, but initial studies report a tolerable side effect profile Serious Risks (Rare) Pancreatitis Gallbladder disease Risk of thyroid C-cell tumors (observed in rodent studies) Note: These drugs should not be administered in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2)

Phase 2 first patient dosed January 2026, and the Phase 1 readout showed up to ~10% weight loss in four weeks in individual patients on a long-acting PK profile

Because the medication slows down the movement of food, the colon has more time to absorb water from the waste

Tell your doctor if you experience any of these effects

IR and IGF1R have overlapping downstream signalling cascades 2,8 , but it is unclear how the hybrid receptors are signalling